Latest Insider Transactions at National Healthcare Corp (NHC)
This section provides a real-time view of insider transactions for National Healthcare Corp (NHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NATIONAL HEALTHCARE CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NATIONAL HEALTHCARE CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2025
|
Ben Anderson Sr Flatt Senior VP & CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,385
-14.11%
|
$326,745
$137.29 P/Share
|
|
Dec 01
2025
|
Ben Anderson Sr Flatt Senior VP & CIO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,734
+18.09%
|
$235,242
$63.96 P/Share
|
|
Nov 25
2025
|
Vicki L Dodson Sr.VP Patient Srvcs |
SELL
Payment of exercise price or tax liability
|
Direct |
3,140
-22.84%
|
$430,180
$137.95 P/Share
|
|
Nov 25
2025
|
Vicki L Dodson Sr.VP Patient Srvcs |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+22.54%
|
$376,000
$94.1 P/Share
|
|
Nov 25
2025
|
Emil E Hassan Director |
SELL
Open market or private sale
|
Direct |
7,500
-10.26%
|
$1,035,000
$138.52 P/Share
|
|
Nov 25
2025
|
Stephen Fowler Flatt CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,853
+2.95%
|
$98,209
$53.94 P/Share
|
|
Nov 21
2025
|
Stephen Fowler Flatt CEO |
SELL
Open market or private sale
|
Direct |
1,000
-1.66%
|
$130,000
$130.33 P/Share
|
|
Nov 12
2025
|
Emil E Hassan Director |
SELL
Open market or private sale
|
Direct |
5,500
-7.0%
|
$731,500
$133.0 P/Share
|
|
Nov 11
2025
|
Robert Michael Ussery President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,425
-1.65%
|
$716,100
$132.2 P/Share
|
|
Nov 11
2025
|
Robert Michael Ussery President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+2.67%
|
$666,000
$74.02 P/Share
|
|
Nov 11
2025
|
Timothy J. Shelly Sr.VP Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
4,746
-62.35%
|
$626,472
$132.2 P/Share
|
|
Nov 11
2025
|
Timothy J. Shelly Sr.VP Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
7,200
+48.2%
|
$417,600
$58.95 P/Share
|
|
Nov 11
2025
|
Josh A Mc Creary Senior VP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,278
-23.9%
|
$432,696
$132.2 P/Share
|
|
Nov 11
2025
|
Josh A Mc Creary Senior VP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+22.58%
|
$376,000
$94.1 P/Share
|
|
Nov 11
2025
|
Brian F Kidd SVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,224
-11.63%
|
$425,568
$132.2 P/Share
|
|
Nov 11
2025
|
Brian F Kidd SVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+12.61%
|
$376,000
$94.1 P/Share
|
|
Nov 11
2025
|
Stephen Fowler Flatt CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,480
-3.96%
|
$327,360
$132.2 P/Share
|
|
Nov 11
2025
|
Stephen Fowler Flatt CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+4.57%
|
$282,000
$94.1 P/Share
|
|
Sep 19
2025
|
Robert G Adams Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,500
+24.89%
|
$319,500
$71.64 P/Share
|
|
Aug 22
2025
|
Stephen Fowler Flatt CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,146
-2.57%
|
$358,644
$114.82 P/Share
|
|
Aug 22
2025
|
Stephen Fowler Flatt CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+3.17%
|
$296,000
$74.02 P/Share
|
|
Aug 13
2025
|
Josh A Mc Creary Senior VP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,737
-21.98%
|
$295,596
$108.82 P/Share
|
|
Aug 13
2025
|
Josh A Mc Creary Senior VP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+24.31%
|
$212,000
$53.94 P/Share
|
|
Aug 13
2025
|
James Paul Abernathy Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,639
-6.76%
|
$285,012
$108.82 P/Share
|
|
Aug 13
2025
|
James Paul Abernathy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,010
+9.32%
|
$284,710
$71.64 P/Share
|
|
Jun 26
2025
|
Robert Michael Ussery President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,007
-1.25%
|
$218,763
$109.05 P/Share
|
|
Jun 26
2025
|
Robert Michael Ussery President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,234
+2.58%
|
$266,742
$63.96 P/Share
|
|
Jun 26
2025
|
Stephen Fowler Flatt CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,557
-5.71%
|
$387,713
$109.05 P/Share
|
|
Jun 26
2025
|
Stephen Fowler Flatt CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,734
+7.06%
|
$298,242
$63.96 P/Share
|
|
Jun 26
2025
|
Vicki L Dodson Sr.VP Patient Srvcs |
SELL
Bona fide gift
|
Direct |
788
-8.08%
|
-
|
|
Jun 12
2025
|
Vicki L Dodson Sr.VP Patient Srvcs |
SELL
Payment of exercise price or tax liability
|
Direct |
5,265
-22.15%
|
$547,560
$104.56 P/Share
|
|
Jun 12
2025
|
Vicki L Dodson Sr.VP Patient Srvcs |
BUY
Exercise of conversion of derivative security
|
Direct |
7,467
+23.93%
|
$433,086
$58.95 P/Share
|
|
Jun 06
2025
|
Josh A Mc Creary Senior VP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,805
-24.92%
|
$297,330
$106.1 P/Share
|
|
Jun 06
2025
|
Josh A Mc Creary Senior VP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,734
+24.91%
|
$235,242
$63.96 P/Share
|
|
Jun 03
2025
|
Richard F Laroche Jr Director |
SELL
Bona fide gift
|
Direct |
152
-0.07%
|
$15,808
$104.69 P/Share
|
|
May 16
2025
|
Brian F Kidd SVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,701
-10.23%
|
$291,708
$108.61 P/Share
|
|
May 16
2025
|
Brian F Kidd SVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,734
+12.39%
|
$235,242
$63.96 P/Share
|
|
May 05
2025
|
Richard F Laroche Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.37%
|
$320,000
$64.64 P/Share
|
|
May 02
2025
|
W Andrew Adams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+2.71%
|
$480,000
$64.64 P/Share
|
|
Apr 25
2025
|
Emil E Hassan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,500
+6.54%
|
$352,000
$64.64 P/Share
|
|
Mar 05
2025
|
Josh A Mc Creary Senior VP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
1,385
+15.55%
|
-
|
|
Mar 05
2025
|
Stephen Fowler Flatt CEO |
BUY
Grant, award, or other acquisition
|
Direct |
2,914
+4.82%
|
-
|
|
Mar 05
2025
|
Ben Anderson Sr Flatt Senior VP & CIO |
BUY
Grant, award, or other acquisition
|
Direct |
1,275
+8.83%
|
-
|
|
Mar 05
2025
|
Vicki L Dodson Sr.VP Patient Srvcs |
BUY
Grant, award, or other acquisition
|
Direct |
946
+11.14%
|
-
|
|
Mar 05
2025
|
Brian F Kidd SVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
1,418
+5.88%
|
-
|
|
Mar 05
2025
|
Robert Michael Ussery President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
2,683
+1.69%
|
-
|
|
Feb 24
2025
|
Sandra Y. Trail Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,886
+20.09%
|
$130,134
$69.19 P/Share
|
|
Feb 20
2025
|
James Paul Abernathy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,745
+4.75%
|
$123,895
$71.64 P/Share
|
|
Jan 01
2025
|
Robert Michael Ussery President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,194
-0.77%
|
$127,758
$107.56 P/Share
|
|
Jan 01
2025
|
Brian F Kidd SVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
512
-2.35%
|
$54,784
$107.56 P/Share
|